104 related articles for article (PubMed ID: 2788375)
1. T cell responses to a Parietaria judaica pollen extract: comparison between Parietaria-sensitive patients, other atopics and healthy controls.
Di Felice G; Mari A; Mucci N; Afferni C; Bruno G; Pini C
Allergy; 1989 Jul; 44(5):322-9. PubMed ID: 2788375
[TBL] [Abstract][Full Text] [Related]
2. T-cell and antibody response to Parietaria judaica allergenic fractions in atopic and nonatopic individuals.
Sallusto F; Quintieri F; Pugliese O; Reale G; Pini C; Di Felice G
Allergy; 1993 Jan; 48(1):37-44. PubMed ID: 8457024
[TBL] [Abstract][Full Text] [Related]
3. Possible relationship between systemic side effects and sensitization to rPar j 2 in allergic patients submitted to an ultra-rush (20 min) sublingual immunotherapy and selected by component resolved diagnosis.
Rossi RE; Monasterolo G; Coco G; Operti D
Int Arch Allergy Immunol; 2005 Oct; 138(2):105-10. PubMed ID: 16174987
[TBL] [Abstract][Full Text] [Related]
4. Role of carbohydrate moieties in cross-reactivity between different components of Parietaria judaica pollen extract.
Mucci N; Liberatore P; Federico R; Forlani F; Di Felice G; Afferni C; Tinghino R; De Cesare F; Pini C
Allergy; 1992 Aug; 47(4 Pt 2):424-30. PubMed ID: 1280917
[TBL] [Abstract][Full Text] [Related]
5. Parietaria judaica-specific T-cell clones from atopic patients: heterogeneity in restriction, V beta usage, and cytokine profile.
Sallusto F; Corinti S; Pini C; Biocca MM; Bruno G; Di Felice G
J Allergy Clin Immunol; 1996 Feb; 97(2):627-37. PubMed ID: 8621848
[TBL] [Abstract][Full Text] [Related]
6. Identification of cross-reactive and genuine Parietaria judaica pollen allergens.
Stumvoll S; Westritschnig K; Lidholm J; Spitzauer S; Colombo P; Duro G; Kraft D; Geraci D; Valenta R
J Allergy Clin Immunol; 2003 May; 111(5):974-9. PubMed ID: 12743560
[TBL] [Abstract][Full Text] [Related]
7. Allergy to Parietaria officinalis pollen.
Cvitanović S
Croat Med J; 1999 Mar; 40(1):42-8. PubMed ID: 9933896
[TBL] [Abstract][Full Text] [Related]
8. Biological characterization of glutaraldehyde-modified Parietaria judaica pollen extracts.
Ibarrola I; Sanz ML; Gamboa PM; Mir A; Benahmed D; Ferrer A; Arilla MC; Martínez A; Asturias JA
Clin Exp Allergy; 2004 Feb; 34(2):303-9. PubMed ID: 14987312
[TBL] [Abstract][Full Text] [Related]
9. Sublingual specific immunotherapy reduces PBMC proliferations.
Fenoglio D; Puppo F; Cirillo I; Vizzaccaro A; Ferrera A; Tosca MA; Marseglia G; Ciprandi G
Eur Ann Allergy Clin Immunol; 2005 Apr; 37(4):147-51. PubMed ID: 15916016
[TBL] [Abstract][Full Text] [Related]
10. Pollinex Parietaria (Bencard Parietaria), a new allergoid for treatment of patients sensitive to Parietaria pollen.
Resta O; Carnimeo N; Foschino MP; Taylor I; Wheeler AW; Youlten LJ
J Investig Allergol Clin Immunol; 1991 Apr; 1(2):129-37. PubMed ID: 1669569
[TBL] [Abstract][Full Text] [Related]
11. Genetically engineered hybrid proteins from Parietaria judaica pollen for allergen-specific immunotherapy.
González-Rioja R; Ibarrola I; Arilla MC; Ferrer A; Mir A; Andreu C; Martínez A; Asturias JA
J Allergy Clin Immunol; 2007 Sep; 120(3):602-9. PubMed ID: 17561242
[TBL] [Abstract][Full Text] [Related]
12. Sensitivity to Parietaria officinalis and Parietaria judaica pollen allergens in a Spanish population.
Dreborg S; Basomba A; Einarsson R
Allergol Immunopathol (Madr); 1986; 14(6):499-508. PubMed ID: 3825837
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis of Parietaria judaica pollen allergy using natural and recombinant Par j 1 and Par j 2 allergens.
González-Rioja R; Ferrer A; Arilla MC; Ibarrola I; Viguera AR; Andreu C; Martínez A; Asturias JA
Clin Exp Allergy; 2007 Feb; 37(2):243-50. PubMed ID: 17250697
[TBL] [Abstract][Full Text] [Related]
14. A sensitive monoclonal antibody-based enzyme-linked immunosorbent assay to quantify Parietaria judaica major allergens, Par j 1 and Par j 2.
Arilla MC; González-Rioja R; Ibarrola I; Mir A; Monteseirín J; Conde J; Martínez A; Asturias JA
Clin Exp Allergy; 2006 Jan; 36(1):87-93. PubMed ID: 16393270
[TBL] [Abstract][Full Text] [Related]
15. Parietaria pollinosis in an Atlantic area: clinical and palynological data.
Vidal C; Dopazo A; Aira MJ
J Investig Allergol Clin Immunol; 2001; 11(2):107-11. PubMed ID: 11642568
[TBL] [Abstract][Full Text] [Related]
16. Tolerance and immunological changes of chemically modified allergen vaccine of Parietaria judaica in accelerated schedules.
Asturias JA; Ferrer A; Arilla MC; Andreu C; Madariaga B; Martínez A
Clin Exp Immunol; 2007 Mar; 147(3):491-6. PubMed ID: 17302898
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of cross-reactivity between Holoptelea integrifolia and Parietaria judaica.
Sharma S; Panzani RC; Gaur SN; Ariano R; Singh AB
Int Arch Allergy Immunol; 2005 Feb; 136(2):103-12. PubMed ID: 15650307
[TBL] [Abstract][Full Text] [Related]
18. Seasonal variations in T-lymphocyte response to grass pollen allergens from pollen-allergic patients and healthy controls.
Jepsen KF; Nielsen L; Olsen OT; Bendtzen K; Poulsen LK
Exp Clin Immunogenet; 1998; 15(3):144-53. PubMed ID: 9813412
[TBL] [Abstract][Full Text] [Related]
19. Cross-reactivity between
Cancelliere N; Iglesias I; Ayuga Á; Enrique Miranda E
Biomed Rep; 2020 Jun; 12(6):326-332. PubMed ID: 32346476
[No Abstract] [Full Text] [Related]
20. Hyposensitization therapy of Parietaria-sensitive patients with a tyrosine adsorbed allergoid, Pollinex Parietaria (Bencard Parietaria).
Bonifazi F; Antonicelli L; Bilò MB; Pucci S; Taylor IH; Wheeler AW; Youlten LJ
J Investig Allergol Clin Immunol; 1991 Feb; 1(1):37-44. PubMed ID: 1669563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
